Gilead Sciences Netherlands organises a live streamed online symposium “Building Cell Therapy in the Netherlands” on the 10th of September from 3pm until 5pm. This event is part of the coming festivities around the opening of the state-of-the-art Kite production facility in Hoofddorp, the Netherlands.
The event will be hosted by Mr. Donatello Piras and is streamed live from the Tobacco Theater in Amsterdam. During this event, we will present you a variety of interesting speakers that will cover different topics around the innovative CAR T-cell therapy in general and the potential impact these treatment options bring to patients, medical doctors and the Netherlands in general.
Speakers
Dr. Sander Veltkamp (Medical Director, Gilead Sciences, The Netherlands)
- The Journey of Bridging Innovation -
Louis van de Wiel (Vice President-Site Head EU Manufacturing, Kite Pharma)
- The CAR T cell journey -
Dr. Mirjam Heemskerk (Head of Laboratory of Experimental Hematology, LUMC)
- Directing patients own immune T-cells to fight cancer -
Prof. dr. Marie José Kersten (Hematologist, Amsterdam UMC)
- Novelty of CAR T-cell therapy and the potential benefit for DLBCL patients -
Bregje Verhoeven (Patient Organisation Representative, Hematon)
- The importance of developing innovative therapies for and with patients -
Registration
To register for the live event, click on the button below and fill in this personal code which gives you access to the registration page. After registration you will receive a confirmation by email.
Code: HF7HWEWN
For any questions, don’t hesitate to reach out via info@GileadCARTsymposium.nl.